Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

113 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cellular and molecular features of COVID-19 associated ARDS: therapeutic relevance.
Scaramuzzo G, Nucera F, Asmundo A, Messina R, Mari M, Montanaro F, Johansen MD, Monaco F, Fadda G, Tuccari G, Hansbro NG, Hansbro PM, Hansel TT, Adcock IM, David A, Kirkham P, Caramori G, Volta CA, Spadaro S. Scaramuzzo G, et al. Among authors: montanaro f. J Inflamm (Lond). 2023 Mar 20;20(1):11. doi: 10.1186/s12950-023-00333-2. J Inflamm (Lond). 2023. PMID: 36941580 Free PMC article. Review.
Cerebro-spinal fluid glucose and lactate concentrations changes in response to therapies in patIents with primary brain injury: the START-TRIP study.
Gouvêa Bogossian E, Taleb C, Aspide R, Badenes R, Battaglini D, Bilotta F, Blandino Ortiz A, Caricato A, Castioni CA, Citerio G, Ferraro G, Martino C, Melchionda I, Montanaro F, Monleon Lopez B, Nato CG, Piagnerelli M, Picetti E, Robba C, Simonet O, Thooft A, Taccone FS. Gouvêa Bogossian E, et al. Among authors: montanaro f. Crit Care. 2023 Mar 31;27(1):130. doi: 10.1186/s13054-023-04409-6. Crit Care. 2023. PMID: 37004053 Free PMC article.
2012 Briganti nomogram predict prostate cancer progression in EAU intermediate risk with unfavorable tumor grade: A single center experience.
Porcaro AB, Costantino S, Brancelli C, Baielli A, Artoni F, Montanaro F, Gallina S, Bianchi A, Serafin E, Veccia A, Franceschini A, Rizzetto R, Brunelli M, Migliorini F, Bertolo RG, Cerruto MA, Antonelli A. Porcaro AB, et al. Among authors: montanaro f. Urologia. 2024 May 23:3915603241252911. doi: 10.1177/03915603241252911. Online ahead of print. Urologia. 2024. PMID: 38780183
The 2012 Briganti nomogram not only predicts lymph node involvement but also disease progression in surgically treated intermediate-risk prostate cancer patients with PSA <10 ng/mL, ISUP grade group 3, and clinical stage up to cT2b.
Porcaro AB, Panunzio A, Orlando R, Montanaro F, Baielli A, Artoni F, Gallina S, Bianchi A, Mazzucato G, Serafin E, Patuzzo GM, Veccia A, Rizzetto R, Brunelli M, Migliorini F, Bertolo R, Tafuri A, Cerruto MA, Antonelli A. Porcaro AB, et al. Among authors: montanaro f. Int Braz J Urol. 2024 Jul-Aug;50(4):450-458. doi: 10.1590/S1677-5538.IBJU.2024.0003. Int Braz J Urol. 2024. PMID: 38743063 Free article.
Trimodal therapy vs radical cystectomy in patients with muscle-invasive bladder cancer: a systematic review and meta-analysis of comparative studies.
Ditonno F, Veccia A, Montanaro F, Pettenuzzo G, Franco A, Manfredi C, Triggiani L, De Nunzio C, De Sio M, Cerruto M, Crivellaro S, Kutikov A, Autorino R, Antonelli A. Ditonno F, et al. Among authors: montanaro f. BJU Int. 2024 Apr 15. doi: 10.1111/bju.16366. Online ahead of print. BJU Int. 2024. PMID: 38622957 Review.
Intraoperative Performance of DaVinci Versus Hugo RAS During Radical Prostatectomy: Focus on Timing, Malfunctioning, Complications, and User Satisfaction in 100 Consecutive Cases (the COMPAR-P Trial).
Antonelli A, Veccia A, Malandra S, Rizzetto R, De Marco V, Baielli A, Franceschini A, Fumanelli F, Montanaro F, Palumbo I, Pettenuzzo G, Roggero L, Angela Cerruto M, Bertolo R; Collaborators. Antonelli A, et al. Among authors: montanaro f. Eur Urol Open Sci. 2024 Apr 4;63:104-112. doi: 10.1016/j.euros.2024.03.013. eCollection 2024 May. Eur Urol Open Sci. 2024. PMID: 38591096 Free PMC article.
Tumor upgrading among very favorable intermediate-risk prostate cancer patients treated with robot-assisted radical prostatectomy: how can it impact the clinical course?
Porcaro AB, Bianchi A, Panunzio A, Gallina S, Serafin E, Tafuri A, Trabacchin N, Orlando R, Ornaghi PI, Mazzucato G, Vidiri S, D'Aietti D, Montanaro F, Brusa D, Patuzzo GM, Artoni F, Baielli A, Migliorini F, De Marco V, Veccia A, Brunelli M, Siracusano S, Cerruto MA, Antonelli A. Porcaro AB, et al. Among authors: montanaro f. Int Urol Nephrol. 2024 Mar 30. doi: 10.1007/s11255-024-04019-3. Online ahead of print. Int Urol Nephrol. 2024. PMID: 38553619
The 2012 Briganti nomogram predicts disease progression in surgically treated intermediate-risk prostate cancer patients with favorable tumor grade group eventually associated with some adverse factors.
Porcaro AB, Orlando R, Panunzio A, Tafuri A, Baielli A, Artoni F, Montanaro F, Gallina S, Bianchi A, Mazzucato G, Serafin E, Veccia A, Boldini M, Treccani LP, Rizzetto R, Brunelli M, Migliorini F, Bertolo R, Cerruto MA, Antonelli A. Porcaro AB, et al. Among authors: montanaro f. J Robot Surg. 2024 Mar 23;18(1):134. doi: 10.1007/s11701-024-01886-x. J Robot Surg. 2024. PMID: 38520651
113 results